Variability of ferritin measurements in chronic kidney disease; implications for iron management

被引:47
|
作者
Ford, Bradley A. [1 ]
Coyne, Daniel W. [2 ]
Eby, Charles S. [1 ,2 ]
Scott, Mitchell G. [1 ]
机构
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Dept Med, St Louis, MO 63110 USA
关键词
ferritin; iron; hemodialysis; anemia; ANEMIC HEMODIALYSIS-PATIENTS; HIGH SERUM FERRITIN; INTRAVENOUS IRON; TRANSFERRIN SATURATION; DIALYSIS PATIENTS; IV IRON; DEFICIENCY; GLUCONATE; TRIAL; REDUCTION;
D O I
10.1038/ki.2008.526
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Serum ferritin levels are a proxy measure of iron stores; existing guidelines for managing anemia in hemodialysis patients suggest that serum ferritin concentrations should be maintained at > 200 ng/ml. The KDOQI recommendations further state there is insufficient evidence advocating routine intravenous iron when ferritin levels exceed 500 ng/ml. Here we determined the interassay differences and short-term intraindividual variability of serum ferritin measurements in patients on chronic hemodialysis to illustrate how these variances may affect treatment decisions. Intermethod variations of up to 150 ng/ml were found comparing six commonly used ferritin assays that evaluated thirteen pools of serum from hemodialysis and nonhemodialysis patients. The intraindividual variability for ferritin in 60 stable hemodialysis patients ranged between 2-62% measured over an initial two-week period and from 3-52% when factored over a six-week period. Our results suggests that single serum ferritin values should not be used to guide clinical decisions regarding treatment of chronic hemodialysis patients with intravenous iron due to significant analytical and intraindividual variability.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 50 条
  • [1] Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease
    Ueda, Norishi
    Takasawa, Kazuya
    NUTRIENTS, 2018, 10 (09)
  • [2] Variability of serum ferritin in chronic kidney disease patients on hemodialysis
    Ford, B. A.
    Hock, K. G.
    Eby, C. S.
    Coyne, D. W.
    Scott, M. G.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A225 - A225
  • [3] Ferritin Iron Content and Hepcidin in Chronic Kidney Disease Patients
    Peter, Barany
    Diala, Merkes-Youssef
    Bo, Brink
    Olof, Heimburger
    Peter, Stenvinkel
    Soheir, Beshara
    BLOOD PURIFICATION, 2009, 28 (04) : 328 - 328
  • [4] Introduction: Iron Management in Chronic Kidney Disease
    Fishbane, Steven
    SEMINARS IN NEPHROLOGY, 2016, 36 (02) : 85 - 86
  • [5] Serum ferritin in chronic kidney disease: Reconsidering the upper limit for iron treatment
    Fishbane, S
    Kalantar-Zadeh, K
    Nissenson, AR
    SEMINARS IN DIALYSIS, 2004, 17 (05) : 336 - 341
  • [6] Iron metabolism and management: focus on chronic kidney disease
    Agarwal, Anil K.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2021, 11 (01) : 46 - 58
  • [7] Ferritin and iron studies in anaemia and chronic disease
    Peng, Ying Y.
    Uprichard, James
    ANNALS OF CLINICAL BIOCHEMISTRY, 2017, 54 (01) : 43 - 48
  • [8] Heme iron polypeptide for the management of anaemia of chronic kidney disease
    Dull, R. B.
    Davis, E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (04) : 386 - 390
  • [9] Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2*MRI
    Nashwan, Abdulqadir J.
    Yassin, Mohamed A.
    Ibrahim, Mohamed Izham Mohamed
    Abdul Rahim, Hanan F.
    Shraim, Mujahed
    FRONTIERS IN MEDICINE, 2022, 9
  • [10] Chronic kidney disease is a cardiovascular problem implications for lipid management
    Wenger, NK
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (02): : 167 - +